Waiver Of Intellectual Property Protections For COVID-19 Vaccine Unlikely To Have Meaningful Impact In Short Term
Intellectual Property Law Blog
MAY 11, 2021
On Wednesday, May 7, 2021, the United States officially endorsed waiving intellectual property protections for COVID-19 vaccines. While the United States has taken the opposite position in recent months, the administration asserts that its departure is guided, at least in part, by the goal “to get as many safe and effective vaccines to as many people as fast as possible.” [1] That goal, however, is unlikely to be affected by such a waiver in the short term due to uncertainty in World Trade Organ
Let's personalize your content